Reversion of frailty
cirrhosis
CIRRHOSIS
At week 8, there was a trend toward higher proportion of frailty reversion in the BCAA group than in the control group (15.4% vs. 0%, P = 0.06). At week 16, the proportion of frailty reversion was significantly higher in the BCAA group (36% vs. 0%, P < 0.001). Subgroup analysis was done separately in Child-Pugh A and B cirrhosis. The proportion of frailty reversion at week 16 was significantly higher in the BCAA group in both Child-Pugh A and B patients (Child A, 27.8% vs. 0%, P = 0.02, and Child B, 57.1% vs. 0%, P = 0.049).